Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses

Näytä kaikki kuvailutiedot



Pysyväisosoite

http://hdl.handle.net/10138/203371

Lähdeviite

Uusi-Rauva , K , Blom , T , von Schantz-Fant , C , Blom , T , Jalanko , A & Kyttala , A 2017 , ' Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses ' , International Journal of Molecular Sciences , vol. 18 , no. 5 , 955 . https://doi.org/10.3390/ijms18050955

Julkaisun nimi: Induced Pluripotent Stem Cells Derived from a CLN5 Patient Manifest Phenotypic Characteristics of Neuronal Ceroid Lipofuscinoses
Tekijä: Uusi-Rauva, Kristiina; Blom, Tea; von Schantz-Fant, Carina; Blom, Tomas; Jalanko, Anu; Kyttala, Aija
Tekijän organisaatio: Department of Medical and Clinical Genetics
University of Helsinki
Medicum
Institute for Molecular Medicine Finland
Department of Anatomy
Päiväys: 2017-05
Kieli: eng
Sivumäärä: 14
Kuuluu julkaisusarjaan: International Journal of Molecular Sciences
ISSN: 1422-0067
DOI-tunniste: https://doi.org/10.3390/ijms18050955
URI: http://hdl.handle.net/10138/203371
Tiivistelmä: Neuronal ceroid lipofuscinoses (NCLs) are autosomal recessive progressive encephalopathies caused by mutations in at least 14 different genes. Despite extensive studies performed in different NCL animal models, the molecular mechanisms underlying neurodegeneration in NCLs remain poorly understood. To model NCL in human cells, we generated induced pluripotent stem cells (iPSCs) by reprogramming skin fibroblasts from a patient with CLN5 (ceroid lipofuscinosis, neuronal, 5) disease, the late infantile variant form of NCL. These CLN5 patient-derived iPSCs (CLN5Y392X iPSCs) harbouring the most common CLN5 mutation, c.1175_1176delAT (p.Tyr392X), were further differentiated into neural lineage cells, the most affected cell type in NCLs. The CLN5Y392X iPSC-derived neural lineage cells showed accumulation of autofluorescent storage material and subunit C of the mitochondrial ATP synthase, both representing the hallmarks of many forms of NCLs, including CLN5 disease. In addition, we detected abnormalities in the intracellular organelles and aberrations in neuronal sphingolipid transportation, verifying the previous findings obtained from Cln5-deficient mouse macrophages. Therefore, patient-derived iPSCs provide a suitable model to study the mechanisms of NCL diseases.
Avainsanat: CLN5
iPS cells
NCL
sphingolipid
lysosomal storage disease
JANSKY-BIELSCHOWSKY DISEASE
HUMAN NEUROBLASTOMA-CELLS
LATE INFANTILE NCL
BATTEN-DISEASE
CHOLESTEROL-METABOLISM
ATP SYNTHASE
PROTEIN
VARIANT
ACTIVATION
MUTATIONS
3111 Biomedicine
Vertaisarvioitu: Kyllä
Tekijänoikeustiedot: cc_by
Pääsyrajoitteet: openAccess
Rinnakkaistallennettu versio: publishedVersion


Tiedostot

Latausmäärä yhteensä: Ladataan...

Tiedosto(t) Koko Formaatti Näytä
ijms_18_00955_v2.pdf 3.711MB PDF Avaa tiedosto

Viite kuuluu kokoelmiin:

Näytä kaikki kuvailutiedot